News & Publications
On this page, you can find our publications in different disease areas and all the latest news and updates related to Porsolt.
The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in …
A successful conference so far at the Safety Pharmacology Society annual meeting (SPS 2022) with Sebastien Breche, Kendall Walker PhD., and Sonia …
Porsolt is proud to announce the renewal of its Good Laboratory Practice (GLP) compliance, following a recent external audit by the French …
This one appears in the most recent issue of “International Journal of Molecular Sciences” (Q1 Medicine). The paper highlights the qualities of …
Porsolt is thrilled to have another paper published in oncology: “A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with …
Porsolt, GlioCure, and CHU d’Angers have joined forces in the “Glio Preclinical Solutions (GPS)” collaborative project to develop new and innovative models …
Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how …
A really successful BIO 2022 conference in San Diego last week, consisting of a busy schedule of meetings and concluding with a …
We recently validated two novel reference compounds in our Electrical Amygdala Kindling in vivo model: Retigabine and Perampanel (third generation drug), in keeping …
It’s great being all together again for the Porsolt semi-annual company-wide meeting. contact@porsolt.com www.porsolt.com
